MedTrace Logo

Tailored COVID-19 Testing Support Plan for Francophone African Born Immigrants

NCT05805163 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-04-07

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effectiveness of a culturally sensitive COVID-19 testing intervention designed for Francophone (French speaking) African Born Immigrants (FABI) . The main question this study aims to answer is whether or not a a culturally sensitive COVID-19 educational pamphlet added to the home-based test will improve testing rates compared to receiving a standard home-based test alone.

Conditions

  • COVID19 Testing

Interventions

BEHAVIORAL

FABI tailored COVID-19 testing pamphlet

FABI adapted COVID-19 educational pamphlet

BEHAVIORAL

Standard COVID-19 home-based test kit

Standard COVID-19 home-based test kit

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Texas Woman's University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2024-04-30
Completion
2024-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05805163 on ClinicalTrials.gov